MeiraGTx appoints Debra Yu, MD to Board of Directors

MeiraGTx Holdings plc

Dr. Yu appointed effective April 25, 2022 as Class II director; term expires at 2023 annual meeting.
Recommended by largest shareholder Perceptive Advisors and senior management.
Currently President and Chief Strategy Officer of LianBio; over 30 years healthcare industry experience.
Previously held senior positions at Pfizer, Labrador Advisors, and two life science VC firms.
Eligible for compensation under Company's Non-Employee Director Compensation Program.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Debra Yu

Class II director

MGTX · MeiraGTx Holdings plc

Effective: 2022-04-25
Filed: April 27, 2022, 7:59 PM ET

On April 25, 2022, the Board of Directors (the “Board”) of MeiraGTx Holdings plc (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Debra Yu, M.D. to the Board as a Class II director, effective immediately, with a term that expires at the Company’s 2023 annual meeting of shareholders and until her successor is duly elected and qualified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Debra Yu was appointed as Class II director at MeiraGTx Holdings plc.

Action: appointed
Role: Class II director

Exact text from the filing

On April 25, 2022, the Board of Directors (the “Board”) of MeiraGTx Holdings plc (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Debra Yu, M.D. to the Board as a Class II director, effective immediately, with a term that expires at the Company’s 2023 annual meeting of shareholders and until her successor is duly elected and qualified.

View on SEC.gov

MeiraGTx Holdings plc filing history →

Source: SEC EDGAR

accession 0001558370-22-006046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.